Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.
Obatala Sciences has raised $3.0M in total funding. The most recent round was Series A. The last funding was announced in October 2022.
Obatala Sciences's investors include Creative Destruction Lab, Elevate Capital, Benson Capital Partners, Corridor Ventures, The Hackett Group.
Obatala Sciences is headquartered in New Orleans, United States.
Obatala Sciences is an assay and research tool development tissue-chip company that specializes in fat-chips.
Obatala Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Obatala Sciences — Funding & Investors." VCBacked, October 13, 2022, https://www.vcbacked.co/company/obatala-sciences. Accessed August 15, 2026.
VCBacked. (2022). Obatala Sciences — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/obatala-sciences
{{cite web |title=Obatala Sciences — Funding & Investors |url=https://www.vcbacked.co/company/obatala-sciences |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated